Clinical Trial

Exercise During Chemotherapy Treatment As Adjuvant Program in Patients with Lymphoma: EDONOLA Study.

Recruiting
View on ClinicalTrials.gov →
Summary
In people diagnosed with lymphoma receiving immunochemotherapy treatment, a combined exercise intervention, as opposed to the general recommendations, will achieve: 1.Improve cardiorespiratory fitness, strength, psychological well-being and quality of life. //2.Reduce fatigue//3.Reduce frailty There is an association between some biological biomarkers with physical capacity and frailty.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-10-25; most recent amendment 2025-02-18.
Status change: Active, Not Recruiting → Recruiting 2025-02-18
Trial Details
NCT Number NCT06660446
Lead Sponsor Biogipuzkoa Health Research Institute
Conditions Lymphoma
Enrollment 180 participants
Start Date 2024-10-08
Primary Completion 2027-03-30 (estimated)
Study Completion 2027-03-30 (estimated)
Updated on ClinicalTrials.gov 2025-02-19